Filtered By:
Source: The American Journal of Cardiology
Condition: Stroke
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 712 results found since Jan 2013.
Long-term Risk of Atrial Fibrillation and Stroke in Patients with Atrial Septal Defect Diagnosed in Childhood
The aim of this study is to evaluate the long-term risk of atrial fibrillation (AF) and stroke in patients with atrial septal defect (ASD) diagnosed before the age of 18 years. Patients diagnosed with ASD between 1963-2011 were identified through national Danish registers, of which 1,111 fulfilled the inclusion criteria. Each patient was matched with 10 controls on age and gender. Risk of AF and stroke was assessed using Cox proportional hazards regression. Cumulative incidences were calculated using Fine and Gray ’s competing risk regression.
Source: The American Journal of Cardiology - October 30, 2016 Category: Cardiology Authors: Zarmiga Karunanithi, Camilla Nyboe, Vibeke Elisabeth Hjortdal Source Type: research
Triggering of Stroke or Atrial Fibrillation by Percutaneous Coronary Intervention
I have read the article entitled “Percutaneous Coronary Intervention as a Trigger for Stroke” by Varmdal et al. 1 with great interest, recently published in journal. Their estimates indicated a substantially increased risk of ischemic stroke during the first 2 days after percutaneous coronary intervention (PCI). Relative risk t hen decreased gradually but stayed elevated for 8 weeks. Increased awareness of this vulnerable period after PCI in clinicians and patients could contribute to earlier detection and treatment for patients suffering a postprocedural stroke 1.
Source: The American Journal of Cardiology - January 2, 2017 Category: Cardiology Authors: Levent Cerit Source Type: research
Comparison of Morphological Features and Flow Velocity of the Left Atrial Appendage among Patients with Atrial Fibrillation Alone, Transient Ischemic Attack and Cardioembolic Stroke
The left atrial appendage (LAA) is a major source of emboli responsible for cardioembolic stroke (CES). We hypothesized that there could be differences in the morphological and functional features of LAAs among patients with atrial fibrillation (AF) alone, patients with cardioembolic transient ischemic attack (CETIA) and patients with CES. Patients with AF and CETIA/CES were included in either a CETIA group or a CES group. Patients with AF without past histories of stroke were included in an AF/non-CVA group.
Source: The American Journal of Cardiology - February 27, 2017 Category: Cardiology Authors: Yonggu Lee, Hwan-Cheol Park, Youkyung Lee, Soon-Gil Kim Source Type: research
Comparison of Morphologic Features and Flow Velocity of the Left Atrial Appendage Among Patients With Atrial Fibrillation Alone, Transient Ischemic Attack, and Cardioembolic Stroke
The left atrial appendage (LAA) is a major source of emboli responsible for cardioembolic stroke (CES). We hypothesized that there could be differences in the morphologic and functional features of LAAs among patients with atrial fibrillation (AF) alone, patients with cardioembolic transient ischemic attack (CETIA), and patients with CES. Patients with AF and CETIA/CES were included in either a CETIA group or a CES group. Patients with AF without past histories of stroke were included in an AF/non-CVA (cerebrovascular accident) group.
Source: The American Journal of Cardiology - February 28, 2017 Category: Cardiology Authors: Yonggu Lee, Hwan-Cheol Park, Youkyung Lee, Soon-Gil Kim Tags: Arrhythmias and Conduction Disturbances Source Type: research
Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (From the Edoxaban Versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation ENSURE-AF Study)
In the ENSURE-AF study, edoxaban was compared to enoxaparin –warfarin in patients undergoing electrical cardioversion of nonvalvular atrial fibrillation, showing comparable low rates of bleeding and thromboembolism. This ancillary analysis investigated differences in relation to stroke and bleeding risk profiles. Secondly, we determined clinical risk profi les to quality of anticoagulation control in the warfarin arm. Primary efficacy (composite of stroke, systemic embolic event, myocardial infarction, and cardiovascular death) and safety (composite of major and clinically relevant nonmajor bleeding) outcomes and time to...
Source: The American Journal of Cardiology - October 26, 2017 Category: Cardiology Authors: Gregory Y.H. Lip, Jose L. Merino, G. Andrei Dan, Sakis Themistoclakis, Kenneth A. Ellenbogen, Raffaele De Caterina, Assen Goudev, James Jin, Michael Melino, Shannon M. Winters, Andreas Goette Source Type: research
Impact of Cardiorespiratory Fitness on Frequency of Atrial Fibrillation, Stroke and All-Cause Mortality
Benefits of regular exercise on cardiovascular health are well recognized, but the impact of cardiorespiratory fitness on incidence of atrial fibrillation (AF) and stroke, and, particularly, risk of stroke and mortality in patients with AF is less clear. From 1993 through 2010, patients referred for a treadmill exercise test (TMET) at the Mayo Clinic Integrated Stress Center, Rochester, MN were retrospectively identified (N=76,857). From this, 14,094 residents of Olmsted and neighboring counties were selected.
Source: The American Journal of Cardiology - November 13, 2017 Category: Cardiology Authors: Nasir Hussain, Bernard J. Gersh, Karina G. Carta, N óra Sydó, Francisco Lopez-Jimenez, Stephen L. Kopecky, Randal J. Thomas, Samuel J. Asirvatham, Thomas G. Allison Source Type: research
Impact of Cardiorespiratory Fitness on Frequency of Atrial Fibrillation, Stroke, and All-Cause Mortality
Benefits of cardiorespiratory fitness on cardiovascular health are well recognized, but the impact on incidence of atrial fibrillation (AF) and stroke, and, particularly, risk of stroke and mortality in patients with AF is less clear. From 1993 to 2010, patients referred for a treadmill exercise test (TMET) at the Mayo Clinic Rochester, MN, were retrospectively identified (N = 76,857). From this, 14,094 local residents were selected. Exclusions were age
Source: The American Journal of Cardiology - November 13, 2017 Category: Cardiology Authors: Nasir Hussain, Bernard J. Gersh, Karina Gonzalez Carta, N óra Sydó, Francisco Lopez-Jimenez, Stephen L. Kopecky, Randal J. Thomas, Samuel J. Asirvatham, Thomas G. Allison Source Type: research
Effect on Risk of Stroke and Acute Myocardial Infarction of Nonselective Nonsteroidal Anti-Inflammatory Drugs in Patients with Rheumatoid Arthritis
There are still debates on the association of increased cardiovascular risk with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in rheumatoid arthritis (RA) patients because of inconsistent results. Therefore, our study aims to evaluate the transient effects of selective and nonselective NSAIDs on the risk of stroke and acute myocardial infarction (AMI) in patients with RA. We conducted a case-crossover study of 5,921 stroke or AMI patients with comorbidity of RA. All cases were identified from the Taiwan National Health Insurance Database between January 1, 2006, through December 31, 2011 according to the Intern...
Source: The American Journal of Cardiology - February 12, 2018 Category: Cardiology Authors: Yih-Ru Chen, Fang-I Hsieh, Chi-Ching Chang, Nai-Fang Chi, Hsin-Chiao Wu, Hung-Yi Chiou Source Type: research
Stroke and Cardiovascular Events after Ablation or Anti-Arrhythmic Drugs for Treatment of Patients with Atrial Fibrillation
Catheter ablation and anti-arrhythmic drugs (AADs) are the most common rhythm-control strategies for atrial fibrillation (AF). Data comparing the rate of stroke and cardiovascular events between the treatment strategies are limited. Therefore, this observational study uses claims data to compare rate of cardiovascular hospitalization and stroke for patients with AF treated with ablation or AADs. Patients in the MarketScan dataset with AF between January 2010 and December 2014 were categorized in the ablation group if an atrial catheter ablation was performed, or in the AAD group if a relevant AAD was prescribed for AF but ...
Source: The American Journal of Cardiology - February 12, 2018 Category: Cardiology Authors: Moussa Mansour, E. Kevin Heist, Rahul Agarwal, T. Jared Bunch, Edward Karst, Jeremy N. Ruskin, Srijoy Mahapatra Source Type: research
Usefulness of the CHA2DS2-VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients with Atrial Fibrillation (From the FibStroke Study)
CHA2DS2-VASc and HAS-BLED scores stratify the risk of thromboembolic and bleeding events respectively in patients with atrial fibrillation (AF). There is only little information on how they differentiate which of the 2 clinically most important complications (ischemic stroke, IS or an intracranial bleeding, IB) the patient is more prone to suffer. We evaluated both scores in patients suffering either of these major complications. The FibStroke Study collected data on all patients with AF suffering either an ischemic stroke or an intracranial bleeding event between 2003-2012 in 4 Finnish hospital districts.
Source: The American Journal of Cardiology - February 12, 2018 Category: Cardiology Authors: Samuli Jaakkola, Tuomas O. Kiviniemi, Ilpo Nuotio, Juha Hartikainen, Pirjo Mustonen, Antti Palom äki, Jussi Jaakkola, Antti Ylitalo, Päivi Hartikainen, K.E. Juhani Airaksinen Source Type: research
Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation
Catheter ablation and antiarrhythmic drugs (AADs) are the most common rhythm-control strategies for atrial fibrillation (AF). Data comparing the rate of stroke and cardiovascular events between the treatment strategies are limited. Therefore, this observational study uses claims data to compare rate of cardiovascular hospitalization and stroke for patients with AF treated with ablation or AADs. Patients in the MarketScan dataset with AF between January 2010 and December 2014 were categorized in the ablation group if an atrial catheter ablation was performed, or in the AAD group if a relevant AAD was prescribed for AF but n...
Source: The American Journal of Cardiology - February 12, 2018 Category: Cardiology Authors: Moussa Mansour, E. Kevin Heist, Rahul Agarwal, T. Jared Bunch, Edward Karst, Jeremy N. Ruskin, Srijoy Mahapatra Source Type: research
Effect on Risk of Stroke and Acute Myocardial Infarction of Nonselective Nonsteroidal Anti-Inflammatory Drugs in Patients With Rheumatoid Arthritis
There are still debates on the association of increased cardiovascular risk with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with rheumatoid arthritis (RA) because of inconsistent results. Therefore, our study aims to evaluate the transient effects of selective and nonselective NSAIDs on the risk of stroke and acute myocardial infarction (AMI) in patients with RA. We conducted a case-crossover study of 5,921 stroke or AMI patients with co-morbidity of RA. All cases were identified from the Taiwan National Health Insurance Database between January 1, 2006, and December 31, 2011, according to the Int...
Source: The American Journal of Cardiology - February 12, 2018 Category: Cardiology Authors: Yih-Ru Chen, Fang-I Hsieh, Chi-Ching Chang, Nai-Fang Chi, Hsin-Chiao Wu, Hung-Yi Chiou Source Type: research
Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation
Catheter ablation and antiarrhythmic drugs (AADs) are the most common rhythm-control strategies for atrial fibrillation (AF). Data comparing the rate of stroke and cardiovascular events between the treatment strategies are limited. Therefore, this observational study uses claims data to compare rate of cardiovascular hospitalization and stroke for patients with AF treated with ablation or AADs. Patients in the MarketScan dataset with AF between January 2010 and December 2014 were categorized in the ablation group if an atrial catheter ablation was performed, or in the AAD group if a relevant AAD was prescribed for AF but n...
Source: The American Journal of Cardiology - February 12, 2018 Category: Cardiology Authors: Moussa Mansour, E. Kevin Heist, Rahul Agarwal, T. Jared Bunch, Edward Karst, Jeremy N. Ruskin, Srijoy Mahapatra Source Type: research
Comparison of the Utility of Transesophageal Echocardiography in Patients With Acute Ischemic Stroke and Transient Ischemic Attack Stratified by Age Group ( < 60, 60-80, ≥80 Years)
The objective was to study the utility of transesophageal echocardiography (TEE) in affecting acute ischemic stroke treatment of older adults (age, ≥80 years). Patients hospitalized between January 2010 and February 2015 were included who had TEE ordered as part of their diagnostic workup at a tertiary medical center. We studied 515 hospitalized patients with acute stroke or transient ischemic attack who underwent TEE. The proportion of patie nts with important TEE findings was 35%. However, TEE changed management in only 2.5% of cases.
Source: The American Journal of Cardiology - September 17, 2018 Category: Cardiology Authors: Ryan C. Van Woerkom, Steven J. Lester, Bart M. Demaerschalk, Austin J. LaBanc, Megan L. Davis, Maria F. Coakley, Stephen S. Cha, Susan Wilansky Tags: Original Article Source Type: research
Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared with Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation
Thoracoscopic left atrial appendage (LAA) occlusion is an alternative treatment for stroke prevention in patients with atrial fibrillation. Prospective study comparing thoracoscopic LAA occlusion and warfarin therapy is still lacking. The goal of this prospective cohort study was to assess the safety and efficacy of thoracoscopic LAA occlusion for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) compared with long-term warfarin therapy. 492 NVAF Patients were enrolled. 257 patients were treated with thoracoscopic LAA occlusion and 235 with long-term warfarin therapy.
Source: The American Journal of Cardiology - September 26, 2018 Category: Cardiology Authors: Mingjie Fu, Zheng Qin, Shuai Zheng, Yueping Li, Shiwei Yang, Yingxin Zhao, Chengping Hu, Kuo Zhou, Yujie Zhou, Xu Meng Source Type: research
